Results
|
1.
|
Beneficial effects of once-daily lixisenatide on overall and postprandial glycemic levels without significant excess of hypoglycemia in type 2 diabetes inadequately controlled on a sulfonylurea with or without metformin (GetGoal-S). MedStar authors:
Year: 2014
Citation: - Journal of Diabetes & its Complications. 28(3):386-92, 2014 May-Jun.
Institution: - MedStar Health Research Institute
Medline publication type:
- Clinical Trial, Phase III
- Journal Article
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Boka G, Hanefeld M, Min KW, Miossec P, Muehlen-Bartmer I, Ratner RE, Rosenstock J, Shamanna P, Zhou T
|
|
2.
|
Similar clinical benefits from below-target and target dose enalapril in patients with heart failure in the SOLVD Treatment trial. MedStar authors:
- Dooley, Daniel J
- Lam, Phillip H
Year: 2018
Citation: - European Journal of Heart Failure. 20(2):359-369, 2018 02.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Aban IB, Adamopoulos C, Ahmed A, Allman RM, Anker SD, Aronow WS, Arundel C, Bhatt DL, Blackman MR, Butler J, Deedwania P, Dooley DJ, Filippatos GS, Fletcher RD, Fonarow GC, Forman DE, Kanonidis IE, Lam PH, Patel K, Pitt B, White M
|
|
3.
|
AZD3293: Pharmacokinetic and Pharmacodynamic Effects in Healthy Subjects and Patients with Alzheimer's Disease. MedStar authors:
Year: 2017
Citation: - Journal of Alzheimer's Disease. 55(3):1039-1053, 2017
Medline publication type:
- Clinical Trial, Phase I
- Journal Article
- Randomized Controlled Trial
All authors: - Alexander RC, Cebers G, Eketjall S, Ereshefsky L, Goldwater R, Haeberlein SB, Han D, Kugler AR, Maltby J, Olsson T, Rosen L, Russell M, Ye N
|
|
4.
|
Impact of intensive glycemic control on the incidence of atrial fibrillation and associated cardiovascular outcomes in patients with type 2 diabetes mellitus (from the Action to Control Cardiovascular Risk in Diabetes Study). MedStar authors:
- Fatemi, Omid
- Yuriditsky, Eugene
Citation: - American Journal of Cardiology. 114(8):1217-22, 2014 Oct 15.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
- Comparative Study
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, N.I.H., Extramural
All authors: - Basile J, Bigger T, Cushman W, Fatemi O, Goff D, Morgan T, Papademetriou V, Soliman EZ, Thomas A, Tsachris D, Tsioufis C, Yuriditsky E
|
|
5.
|
Pharmacokinetics and pharmacodynamics of a single dose Nilotinib in individuals with Parkinson's disease. MedStar authors:
Year: 2019
Citation: - Pharmacology Research & Perspectives. 7(2):e00470, 2019 04.
Institution: - MedStar Washington Hospital Center
Medline publication type:
- Journal Article
- Research Support, Non-U.S. Gov't
All authors: - Ahn J, Arellano J, Fowler AJ, Hebron ML, Howard HH, Lawler A, Liu X, Matar S, Moussa C, Mundel EE, Pagan FL, Peyton M, Schwartz SL, Starr NJ, Torres-Yaghi Y, Wilmarth B, Yusuf N
|
|
6.
|
Neuropsychiatric safety with liraglutide 3.0mg for weight management: results from randomized controlled phase 2 and 3a trials. MedStar authors:
Year: 2017
Citation: - Diabetes, Obesity & Metabolism. 19(11):1529-1536, 2017 Nov.
Institution: - MedStar Health Research Institute
Medline publication type:
All authors: - Aroda VR, Astrup A, Brett J, Cancino A, Kushner R, Lau DC, O'Neil PM, Satiety and Clinical Adiposity - Liraglutide Evidence in individuals with and without diabetes (SCALE) study groups, Wadden TA, Wilding JP
|